Skip to main content

Table 2 Outcomes of CBP and non-CBP groups

From: Continuous Blood purification on Influenza-Associated Neurological Disease in children: a retrospective cohort study

Outcomes CBP group (n=18) Non-CBP group (n=12) p
28-day mortality, n (%)a 2 (11.11) 6 (50) 0.034*
Glasgow score (median [IQR])b 7.00 (4.00-7.25) 3.50 (3.00-5.75) 0.021*
PIM-2 score (median [IQR])b 11.00 (7.78-22.55) 43.80 (9.28-85.03) 0.040*
Critical illness score (median [IQR])b 93 (88.00-94.00) 81 (77.00-93.50) 0.038*
PICU stay (median [IQR]) (d)c 19.00 (15.00-22.50) 10.00 (4.00-12.00) 0.008*
Ventilation time (median [IQR]) (d)c 7.50 (5.75-15.25) 5.50 (4.00-6.75) 0.060
hospitalization costs(median [IQR]) (US dollars)c 11350.67 (8670.36-16802.95) 6195.63 (3246.95-8000.03) 0.008*
  1. CBP Continuous blood purification, IQR Interquartile range, PIM-2 Pediatric index of mortality 2, PICU Pediatric intensive care unit
  2. * p<0.05
  3. a p<0.05 The 28-day mortality using the Chi-squared test
  4. b p<0.05 The Glasgow score, PIM-2 score, Critical ill score using Mann-Whitney U test
  5. c p<0.05 The PICU stay, Ventilation time, Hospitalization costs using nonparametric tests/compare medians across groups